Digipath Inc
OTC:DIGP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Digipath Inc
Other Long-Term Assets
Digipath Inc
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Digipath Inc
OTC:DIGP
|
Other Long-Term Assets
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Long-Term Assets
$256m
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
CVS Health Corp
NYSE:CVS
|
Other Long-Term Assets
$7.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
17%
|
|
|
Cigna Corp
NYSE:CI
|
Other Long-Term Assets
$14.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
44%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Long-Term Assets
$751.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Other Long-Term Assets
$139.7m
|
CAGR 3-Years
31%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
Digipath Inc
Glance View
DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2011-12-23. The Company’s cannabis testing business is operated through its subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant laboratory equipment and processes. The firm is a third-party independent testing laboratory facility for cannabis, cannabis infused products, hemp and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients and eventually all end users of cannabis and botanical products. Its Digipath Labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents, moisture, water activity, visual inspection, pesticides, heavy metals, biological toxins and microbial contaminants.
See Also
What is Digipath Inc's Other Long-Term Assets?
Other Long-Term Assets
0
USD
Based on the financial report for Mar 31, 2024, Digipath Inc's Other Long-Term Assets amounts to 0 USD.
